Radiation Therapy May Cause Bone Loss in Anorectal Cancer Patients
Researchers at Ohio State University conducted a study to examine the effects of radiation therapy (RT) on bone density in patients with anorectal cancer. The study involved reviewing CT scans of 302 patients before and after RT, taking into account factors such as contrast agents and CT tube voltage. The results showed that bone loss occurred within the first three months following the start of RT, with the majority of the decline happening during this time period. The study suggests that bone loss is associated with proximity to the radiation field and that most of the observed decline occurs within the first three months after RT begins.
Key Takeaways:
- The study found that radiation therapy can cause bone loss in patients with anorectal cancer, particularly in the sacral and lumbar regions.
- The majority of the bone loss occurs within the first three months following the start of RT, with the majority of the decline happening during this time period.
- The study suggests that bone loss is associated with proximity to the radiation field, with the sacral and lumbar regions experiencing the most significant decline.
- The research has been peer-reviewed and published in the Journal of Clinical Densitometry, with the study titled "Effect of Radiation Therapy On Ct Attenuation of Bone In Patients With Anorectal Cancer Treated With Chemotherapy."
- The study's findings have implications for the management of patients with anorectal cancer, particularly those undergoing RT, and highlights the need for further research into the effects of RT on bone health.
- The study's results may inform the development of new treatments or recommendations for evaluating bone health prior to RT in patients with anorectal cancer.
Statistics:
- 302 patients with anorectal cancer were included in the study, with all patients undergoing RT as part of their treatment.
- The study found that bone loss occurred at a mean rate of -48.8 HU (31.0%) at the lumbar level and -65.9 HU (28.6%) at the sacral level three months post-RT.
- The study's results showed little to no evidence of further decrease in bone attenuation beyond three months after RT.
- The study's findings suggest that bone loss is associated with proximity to the radiation field, with the sacral and lumbar regions experiencing the most significant decline.
Sources:
- NewsRx. Study Findings from Ohio State University Broaden Understanding of Cancer (Effect of Radiation Therapy On Ct Attenuation of Bone In Patients With Anorectal Cancer Treated With Chemotherapy). Health & Medicine Week. August 8, 2025; p 5388.
- Journal of Clinical Densitometry. (2025;28(3)).
- Elsevier Science Inc. (www.elsevier.com).
- Journal of Clinical Densitometry. (www.journals.elsevier.com/journal-of-clinical-densitometry/).
- Ohio State University. (Columbus, OH 43210, United States).